BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 23960186)

  • 41. β-catenin S45F mutation results in apoptotic resistance.
    Braggio D; Zewdu A; Londhe P; Yu P; Lopez G; Batte K; Koller D; Costas Casal de Faria F; Casadei L; Strohecker AM; Lev D; Pollock RE
    Oncogene; 2020 Aug; 39(34):5589-5600. PubMed ID: 32651460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CORR Insights®: Does the Addition of Mutations of CTNNB1 S45F to Clinical Factors Allow Prediction of Local Recurrence in Patients With a Desmoid Tumor? A Local Recurrence Risk Model.
    Ramsey DC
    Clin Orthop Relat Res; 2023 Oct; 481(10):1990-1992. PubMed ID: 37159234
    [No Abstract]   [Full Text] [Related]  

  • 43. Yield of Colonoscopy in Identification of Newly Diagnosed Desmoid-Type Fibromatosis with Underlying Familial Adenomatous Polyposis.
    van Houdt WJ; Wei IH; Kuk D; Qin LX; Jadeja B; Villano A; Hameed M; Singer S; Crago AM
    Ann Surg Oncol; 2019 Mar; 26(3):765-771. PubMed ID: 30610557
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Possible association between higher beta-catenin mRNA expression and mutated beta-catenin in sporadic desmoid tumors: real-time semiquantitative assay by TaqMan polymerase chain reaction.
    Saito T; Oda Y; Kawaguchi K; Tanaka K; Matsuda S; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Lab Invest; 2002 Jan; 82(1):97-103. PubMed ID: 11796830
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cutaneous desmoid-type fibromatosis: A rare case with molecular profiling.
    Aghighi M; Cloutier JM; Hoover WD; Roy K; Lo AA; Brown RA
    J Cutan Pathol; 2021 Sep; 48(9):1185-1188. PubMed ID: 33978242
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Metabolomics Pilot Study on Desmoid Tumors and Novel Drug Candidates.
    Mercier KA; Al-Jazrawe M; Poon R; Acuff Z; Alman B
    Sci Rep; 2018 Jan; 8(1):584. PubMed ID: 29330550
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors.
    Salas S; Chibon F; Noguchi T; Terrier P; Ranchere-Vince D; Lagarde P; Benard J; Forget S; Blanchard C; Dômont J; Bonvalot S; Guillou L; Leroux A; Mechine-Neuville A; Schöffski P; Laë M; Collin F; Verola O; Carbonnelle A; Vescovo L; Bui B; Brouste V; Sobol H; Aurias A; Coindre JM
    Genes Chromosomes Cancer; 2010 Jun; 49(6):560-8. PubMed ID: 20232483
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical significance of midkine expression in sporadic desmoid tumors.
    Kim HS; Kim J; Nam KH; Kim WH
    Oncol Lett; 2016 Mar; 11(3):1677-1684. PubMed ID: 26998061
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differentially Methylated Regions in Desmoid-Type Fibromatosis: A Comparison Between CTNNB1 S45F and T41A Tumors.
    Timbergen MJM; Boers R; Vriends ALM; Boers J; van IJcken WFJ; Lavrijsen M; Grünhagen DJ; Verhoef C; Sleijfer S; Smits R; Gribnau J; Wiemer EAC
    Front Oncol; 2020; 10():565031. PubMed ID: 33194643
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is mutation analysis of β-catenin useful for the diagnosis of desmoid-type fibromatosis? A systematic review.
    Sakai T; Hamada S; Koike H; Shimizu K; Yoshida M; Nishida Y
    Jpn J Clin Oncol; 2020 Sep; 50(9):1037-1042. PubMed ID: 32533146
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel case of a sporadic desmoid tumour with mutation of the beta catenin gene.
    Shitoh K; Konishi F; Iijima T; Ohdaira T; Sakai K; Kanazawa K; Miyaki M
    J Clin Pathol; 1999 Sep; 52(9):695-6. PubMed ID: 10655994
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Resection of a desmoid-type fibromatosis with a CTNNB1 p.S45P mutation using a cervico-thoracic approach: A case report and literature review.
    Sato R; Bandoh N; Goto T; Uemura A; Inoue N; Otomo Y; Nakano H; Yamaguchi T; Kato Y; Nishihara H; Takei H; Harabuchi Y
    Auris Nasus Larynx; 2021 Aug; 48(4):777-782. PubMed ID: 32505607
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Abnormalities of the Wnt/β-catenin signalling pathway induce tumour progression in sporadic desmoid tumours: correlation between β-catenin widespread nuclear expression and VEGF overexpression.
    Matono H; Tamiya S; Yokoyama R; Saito T; Iwamoto Y; Tsuneyoshi M; Oda Y
    Histopathology; 2011 Sep; 59(3):368-75. PubMed ID: 22034877
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuromuscular Choristoma: Report of Five Cases With CTNNB1 Sequencing.
    Brandao ICS; de Souza FS; de Amoreira Gepp R; Martins BJAF; de Mendonca Cardoso M; Sollaci C; da Cunha IW; Kalil RK
    J Neuropathol Exp Neurol; 2021 Nov; 80(11):1068–1077. PubMed ID: 34718655
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis).
    Kummar S; O'Sullivan Coyne G; Do KT; Turkbey B; Meltzer PS; Polley E; Choyke PL; Meehan R; Vilimas R; Horneffer Y; Juwara L; Lih A; Choudhary A; Mitchell SA; Helman LJ; Doroshow JH; Chen AP
    J Clin Oncol; 2017 May; 35(14):1561-1569. PubMed ID: 28350521
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential diagnosis and mutation stratification of desmoid-type fibromatosis on MRI using radiomics.
    Timbergen MJM; Starmans MPA; Padmos GA; Grünhagen DJ; van Leenders GJLH; Hanff DF; Verhoef C; Niessen WJ; Sleijfer S; Klein S; Visser JJ
    Eur J Radiol; 2020 Oct; 131():109266. PubMed ID: 32971431
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Desmoid Fibromatosis With TP53 Mutation and Striking Nuclear Pleomorphism.
    Foster CR; Strauss M; Hornick JL; Habeeb O
    Int J Surg Pathol; 2023 Dec; 31(8):1565-1571. PubMed ID: 36908221
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Desmoid-type fibromatosis of the head and neck region in the paediatric population: a clinicopathological and genetic study of seven cases.
    Flucke U; Tops BB; van Diest PJ; Slootweg PJ
    Histopathology; 2014 May; 64(6):769-76. PubMed ID: 24206198
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CTNNB1 and APC Mutations in Sinonasal Myxoma : Expanding the Spectrum of Tumors Driven By WNT/β-catenin Pathway.
    Chen S; Gallant S; Cunningham MJ; Robson CD; Church AJ; Perez-Atayde AR; Al-Ibraheemi A
    Am J Surg Pathol; 2023 Nov; 47(11):1291-1300. PubMed ID: 37589277
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sinonasal Myxoma: A Distinct Entity or a Myxoid Variant of Desmoid Fibromatosis?
    Velez Torres JM; Mata DA; Briski LM; Green DC; Cloutier JM; Kerr DA; Montgomery EA; Rosenberg AE
    Mod Pathol; 2023 Jul; 36(7):100189. PubMed ID: 37059229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.